Enhanced photodynamic activity of meso-tetra(4-hydroxyphenyl)porphyrin by incorporation into sub-200 nm nanoparticles

European Journal of Pharmaceutical Sciences

Volumn 18, Issue 3-4, 2003, Pages 241-249

  Konan, Yvette Niamien ^a   Berton, Myriam ^a,b   Gurny, Robert ^a   Allémann, Eric ^a,c  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b NOVARTIS PHARMA AG   (Switzerland)

^c Bracco Suisse SA   (Switzerland)

Author keywords

EMT 6 mammary tumour cells; Meso tetra(4 hydroxyphenyl)porphyrin; Nanoparticles; Photodynamic therapy; Poly(D,L lactide); Poly(D,L lactide co glycolide)

Indexed keywords

DIFFUSION; EMULSIFICATION; ENCAPSULATION; NANOSTRUCTURED MATERIALS; PHOTOSENSITIZERS; PORPHYRINS;

PHOTODYNAMIC ACTIVITY;

DRUG PRODUCTS;

NANOPARTICLE; PHOTOSENSITIZING AGENT; POLYGLACTIN; POLYMER; PORPHYRIN DERIVATIVE; RESOMER; TETRAKIS(4 HYDROXYPHENYL)PORPHYRIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BREAST TUMOR; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DIFFUSION; DRUG FORMULATION; EMULSION; ENCAPSULATION; INCUBATION TIME; MOUSE; NONHUMAN; PHOTODYNAMICS; PRIORITY JOURNAL;

EID: 0037345381     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0987(03)00017-4     Document Type: Article

References (44)

1. Agarwal L.M., Clay M.E., Harvey E.J., Evans H.H., Antunez A.R., Oleinick N.L. Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells. Cancer Res. 51:1991;5993-5996.
2. Allémann E., Rousseau J., Brasseur N., Kudrevich S.V., Lewis K., Van Lier J.E. Photodynamic therapy of tumours with hexadecafluoro zinc phthalocyanine formulated in PEG-coated poly(lactic acid) nanoparticles. Int. J. Cancer. 66:1996;821-824.
3. 6 in human bladder carcinoma cells. Cancer Res. 51:1991;4410-4414.
4. 6 in the photodynamic therapy of human bladder carcinoma cells. J. Urol. 146:1991;1654-1658.
5. 6-conjugated microspheres. Proc. Natl. Acad. Sci. USA. 88:1991;1580-1584.
6. Barratt G.M. Therapeutic applications of colloidal drug carriers. Pharm. Sci. Techn. Today. 3:2000;163-171.
7. Berenbaum M.C., Akande S.L., Bonnett R., Kaur H., Ioannou S. meso-Tetra(hydroxyphenyl)porphyrins, a new class of potent tumour photosensitisers with favourable selectivity. Br. J. Cancer. 54:1986;717-725.
8. Brasseur N., Brault D., Couvreur P. Adsorption of hematoporphyrin onto polyalkylcyanoacrylate nanoparticles: carrier capacity and drug release. Int. J. Pharm. 70:1991;129-135.
9. Brasseur N., Ouellet R., La Madeleine C., Van Lier J.E. Water-soluble aluminium phthalocyanine-polymer conjugates for PDT: photodynamic activities and pharmacokinetics in tumour-bearing mice. Br. J. Cancer. 80:1999;1533-1541.
10. Davda J., Labhasetwar V. Characterization of nanoparticle uptake by endothelial cells. Int. J. Pharm. 233:2002;51-59.
11. Dougherty T.J., Grindey G.B., Weishaupt K.R., Boyle D. Photoradiation therapy II. Cure of animal tumours with haematoporphyrin and light. J. Natl. Cancer Inst. 55:1975;115-121.
12. Dougherty T.J. Photosensitizers, therapy and detection of malignant tumors. Photochem. Photobiol. 45:1987;879-889.
13. Dougherty T.J., Gomer C.J., Henderson B.W., Jori G., Kessel D., Koberlik M., Moan J., Peng Q. Photodynamic therapy. J. Natl. Cancer Inst. 90:1998;889-904.
14. Dunne M., Corrigan O.I., Ramtoola Z. Influence of particle size and dissolution conditions on the degradation properties of polylactide-co-glycolide particles. Biomaterials. 21:2000;1659-1668.
15. Garbo G.M., Fingar V.H., Wienman T.J., Noakes E.B. III, Haydon P.S., Cerrito P.B., Kessel D.H., Morgan A.R. In vivo and in vitro photodynamic studies with benzochlorin imimium salts delivered by a lipid emulsion. Photochem. Photobiol. 64:1998;561-568.
16. He X.Y., Sikes R.A., Thomsen S., Chung L.W., Jacques S.L. Photodynamic therapy with Photofrin II induces programmed cell death in carcinoma cell lines. Photochem. Photobiol. 59:1994;468-473.
17. Henderson B.W., Bellnier D.A., Greco W.R., Sharma A., Pandey R.K., Vaughan L.A., Weishaupt K.R., Dougherty T.J. An in vivo quantitative structure-activity relationship for a congeneric series of pyropheophorbide derivatives as photosensitizers for photodynamic therapy. Cancer Res. 57:1997;4000-4007.
18. Jori G. Tumour photosensitizers: approaches to enhance the selectivity and efficiency of photodynamic therapy. J. Photochem. Photobiol. B: Biol. 36:1996;87-93.
19. Kawashima Y. Nanoparticulate systems for improved drug delivery. Adv. Drug Deliv. Rev. 47:2001;1-2.
20. Konan Y.N., Gurny R., Allémann E. State of the art in the delivery of photosensitizers for photodynamic therapy. J. Photochem. Photobiol. B: Biol. 66:2002;89-106.
21. Konan Y.N., Gurny R., Allémann E. Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparticles. Int. J. Pharm. 233:2002;239-252.
22. Konan Y.N., Cerny R., Favet J., Berton M., Gurny R., Allémann E. Preparation and characterization of sterile sub-200 nm meso-tetra(4-hydroxyphenyl)porphyrin-loaded nanoparticles for potential use in photodynamic therapy. Eur. J. Pharm. Biopharm. 55:2003;115-124.
23. Kong G., Braun R.D., Dewhirst M.W. Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size. Cancer Res. 60:2000;4440-4445.
24. Kreimer-Birnbaum M. Modified porphyrins, chlorins, phthalocyanines, and purpurins: second generation photosensitizers for photodynamic therapy. Semin. Hematol. 26:1989;157-173.
25. Li S., McCarthy S. Further investigations on the hydrolytic degradation of poly(D,L-lactide). Biomaterials. 20:1999;35-44.
26. Lin C.-W. Photodynamic therapy of malignant tumors - recent developments. Cancer Cells. 3:1991;437-444.
27. Liu D., Mori A., Huang L. Role of liposome size and RES blockade in controlling biodistribution and tumor uptake of GM1-containing liposomes. Biochem. Biophys. Acta. 1104:2002;95-101.
28. Merlin J.-L., Azzi S., Lignon D., Ramacci C., Zeghari N., Guillemin F. MTT assays allow quick and reliable measurement of the response of human tumour cells to photodynamic therapy. Eur. J. Cancer. 28A:1992;1452-1458.
29. Miller J.W., Schmidt-Erfurth U., Sickenberg M., Pournaras C.J., Laqua H., Barbazetto I., Zografos L., Piguet B., Donati G., Lane A.-M., Birngruber R., van den Berg H., Strong H.A., Manjuris U., Gray T., Fsadni M., Bressler N.M., Gragoudas E.S. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related degeneration. Arch. Ophthalmol. 117:1999;1161-1173.
30. Mironov A.F., Nizhnik A.N., Nockel A.Y. Hematoporphyrin derivatives: an oligomeric composition study. J. Photochem. Photobiol. B: Biol. 4:1990;297-306.
31. Nagayasu A., Uchiyama K., Kiwada H. The size of liposomes: a factor which affects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugs. Adv. Drug Deliv. Rev. 40:1999;75-87.
32. Pandey R.K., Sumlin A.B., Constantine S., Aoudia M., Potter W.R., Bellnier D.A., Henderson B.W., Rodgers M.A., Smith K.M., Dougherty T.J. Alkyl ether analogs of chlorophyll-a derivatives: Part 1. Synthesis, photophysical properties and photodynamic efficacy. Photochem. Photobiol. 64:1996;194-204.
33. Park T.G. Degradation of poly(lactic-co-glycolic acid) microspheres: effect of copolymer composition. Biomaterials. 16:1995;1123-1130.
34. Peng Q., Moan J., Ma L.-W., Nesland J.M. Uptake, localization and photodynamic effect of meso-tetra(hydroxyphenyl)porphine and its corresponding chlorin in normal and tumor tissues of mice bearing mammary carcinoma. Cancer Res. 55:1995;2620-2626.
35. Prior S., Gander B., Blarer N., Merkle H.P., Subira M.L., Irache J.M., Gamazo C. In vitro phagocytosis and monocyte-macrophage activation with poly(lactide) and poly(lactide-co-glycolide) microspheres. Eur. J. Pharm. Sci. 15:2002;197-207.
36. Razum N., Balchum O.J., Profio A.E., Carstens F. Skin photosensitivity: duration and intensity following intravenous hematoporphyrin derivatives, HPD and DHE. Photochem. Photobiol. 46:1987;925-928.
37. Renno R.Z., Miller J.W. Photosensitizer delivery for photodynamic therapy of choroidal neovascularization. Adv. Drug Deliv. Rev. 52:2001;63-78.
38. Rezzoug H., Bezdetnaya L., A'amar O., Merlin J.L., Guillemin F. Parameters affecting photodynamic activity of Foscan or meta-tetra(hydroxyphenyl)chlorin (mTHPC) in vitro and in vivo. Lasers Med. Sci. 13:1998;119-125.
39. Ricchelli F., Gobbo S., Jori G., Moreno G., Vinzens F., Salet C. Photosensitization of mitochondria by liposome-bound porphyrins. Photochem. Photobiol. 58:1993;53-58.
40. Sharma A., Sharma U.S. Liposomes in drug delivery: progress and limitations. Int. J. Pharm. 154:1997;123-140.
41. Soubrane C., Bressler N.M. Treatment of subfoveal choroidal neovascularisation in age related macular degeneration: focus on clinical application of veterporfin photodynamic therapy. Br. J. Ophthalmol. 85:2001;483-495.
42. ten Wolde A., Markies B.A., Pieterson W.A., Speckamp W.N. Stability and scanning electron microscopy of Photofrin-II and Photosan-3. J. Photochem. Photobiol. B: Biol. 36:1996;139-142.
43. Wörle D., Muller S., Shopova M., Mantareva V., Spassova G., Vietri F., Ricchelli F., Jori G. Effect of delivery system on the pharmacokinetic and phototherapeutic properties of bis(methyloxyethyleneoxy)silicon-phthalocyanine in tumor-bearing mice. J. Photochem. Photobiol. B: Biol. 50:1999;124-128.
44. Zund G., Ye Q., Hoerstrup S.P., Schoeberlein A., Schmid A.C., Grunenfelder J., Vogt P., Turina M. Tissue engineering in cardiovascular surgery: MTT, a rapid and reliable quantitative method to assess the optimal human cell seeding on polymeric meshes. Eur. J. Cardio-Thoracic Surg. 15:1999;519-524.